Thèses sur le sujet « Modello ischemia in vitro »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleures thèses pour votre recherche sur le sujet « Modello ischemia in vitro ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les thèses sur diverses disciplines et organisez correctement votre bibliographie.
BRESCHI, GIAN LUCA. « STUDIO ANATOMICO E FUNZIONALE DELLA REGIONE DI PENOMBRA IN UN MODELLO DI ISCHEMIA IN VITRO ». Doctoral thesis, Università degli Studi di Milano, 2013. http://hdl.handle.net/2434/215236.
Texte intégralBACIGALUPPI, SUSANNA. « Ruolo e potenziale delle cellule progenitrici endoteliali nel vasospamo cerebrale ». Doctoral thesis, Università degli Studi di Milano-Bicocca, 2011. http://hdl.handle.net/10281/27113.
Texte intégralTsang, Hing-wai, et 曾慶威. « In vitro studies of hypoxic ischemic down-regulated 1 (HID-1) protein encoded by a novel gene down-regulated in neonatal hypoxic-ischemicencephalopathy in different cell death paradigms ». Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B45608192.
Texte intégralBarandier, Christine. « Potentiel thérapeutique du manganèse et de l'un de ses dérivés synthétiques sur le système cardiovasculaire ». Université Joseph Fourier (Grenoble), 1998. http://www.theses.fr/1998GRE10238.
Texte intégralPocar, M. « Perfusione spinale retrograda selettiva durante ischemia da clampaggio aortico : modello sperimentale nel suino ». Doctoral thesis, Università degli Studi di Milano, 2000. http://hdl.handle.net/2434/195626.
Texte intégralPoignet, Hervé. « Activites pharmacologiques des antagonistes du calcium sur differents modeles physiopathologiques utilises dans l'ischemie cerebrale experimentale : effets sur les atteintes fonctionnelles et neuronales ». Clermont-Ferrand 2, 1988. http://www.theses.fr/1988CLF21111.
Texte intégralSAKAMOTO, NOBUO, TATSUAKI MATSUBARA, YOSHIHIRO KAKINUMA et TATSUO HASHIMOTO. « MYOCARDIAL METABOLIC MARKERS OF TOTAL ISCHEMIA IN VITRO ». Nagoya University School of Medicine, 1994. http://hdl.handle.net/2237/15927.
Texte intégralZAMBAITI, ELISA. « Organoidi gastrointestinali pediatrici e fetali : modello di cultura tridimensionale in vitro ». Doctoral thesis, Università degli studi di Padova, 2022. http://hdl.handle.net/11577/3447317.
Texte intégralAims Adult COVID-19 is mainly respiratory illness, but in children GI symptoms are more frequent. Furthermore, fetuses are rarely affected by COVID-19. Organoids are a relatively new tool to in vitro establish long-living culture that three-dimensionally resemble the tissue of origin and may both maintain the stemness and fully differentiate in all cell types. As a proof of concept, we aimed to develop a culture system for gastrointestinal organoids (GIOs) to investigate SARS-CoV-2 infection in gastric epithelium across the lifespan. Methods GIO were derived from 8-21 week fetuses and from pediatric and adult tissues. They were cultured using chemically-defined medium, to test their ability to maintain stemness and to fully differentiate. GIO were analyzed in correlation to the surrounding ECM. Reverse cellular polarity Organoids (RP-GOs) were induced and incubated with SARS-CoV-2. All experiments were analyzed by qPCR, immunofluorescence and qualitative analysis as appropriate. Results Gastrointestinal organoids can be isolated from all gestational ages, demonstrating normal gastric epithelial morphology and expressing mature gastric cell types including, the niche, secretive, and enteroendocrine cells. These cultures may be maintained indefinitely in vitro and cultured in GMP-compliant conditions. RP-GOs exhibit apical-out polarity, exposing ACE2 on the external surface, optimizing conditions for viral infection. Viral nucleoprotein was demonstrated in cells undergoing apoptosis, with pediatric RP-GOs most susceptible and efficiently infected compared to fetal and adult organoids. Conclusions We have successfully established an efficient gastrointestinal organoid culture systems for all ages, from fetal life to adulthood. Organoid-based technology can be used for in vitro disease modelling, drug testing or cell therapy. The application of GMP compliant rules makes the clinical translation closer.
Zwaini, Zinah Dheyaa Razzaq. « In vitro and in vivo models of renal ischemia reperfusion injury ». Thesis, University of Leicester, 2017. http://hdl.handle.net/2381/39344.
Texte intégralChampattanachai, Voraratt. « Effects of hexosamine biosynthesis on an in vitro model of cardiac ischemia ». Thesis, Birmingham, Ala. : University of Alabama at Birmingham, 2008. https://www.mhsl.uab.edu/dt/2008d/champattanachai.pdf.
Texte intégralZur, Nedden Stephanie. « Targeting the purine salvage pathway in in vitro models of cerebral ischemia ». Thesis, University of Warwick, 2011. http://wrap.warwick.ac.uk/45926/.
Texte intégralOLIVETTO, Elena. « IPOACUSIA NEUROSENSORIALE E DANNO ISCHEMICO. MESSA A PUNTO DI UN MODELLO ANIMALE PER VALUTARNE GLI EFFETTI VASCOLARI E OSSIDATIVI ». Doctoral thesis, Università degli studi di Ferrara, 2013. http://hdl.handle.net/11392/2388913.
Texte intégralCAPORALI, SIMONA. « Cellule staminali neuronali e microglia : cross - talk in modello in vitro di neuroinfiammazione ». Doctoral thesis, Università degli Studi di Milano-Bicocca, 2009. http://hdl.handle.net/10281/7547.
Texte intégralFrantseva, Marina. « Mechanisms of free radical formation and toxicity in an in vitro model of ischemia ». Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp02/NQ45776.pdf.
Texte intégralAriga, Suely Kunimi Kubo. « "Modulação térmica da lesão isquêmica : estudo in vitro" ». Universidade de São Paulo, 2005. http://www.teses.usp.br/teses/disponiveis/5/5160/tde-14092006-144005/.
Texte intégralCardiac arrest causes cerebral ischemia and neuronal disappearance. We investigate celular death mechanisms elucidated by a model of ischemia in neuroblastoma cell line. The ischemic insult was reproduced by deprivation of growth factors and glucose in a hypoxic environment produced by an anaerobiosis system. Our results validate the experimental model and revel the participation of an apoptotic process in the celular loss induced by ischemia. We also demonstrated that hypothermia can be used as a neuroprotector agent whereas hyperthermia aggavates celular damage.
Canora, Alice. « Studio del potenziale prebiotico degli alimenti con un modello intestinale in vitro e analisi multi-omiche ». Master's thesis, Alma Mater Studiorum - Università di Bologna, 2021. http://amslaurea.unibo.it/22359/.
Texte intégralPALOMBI, CECILIA. « Ruolo delle cellule T regolatorie in vitro e in vivo in un modello di colite autoimmune ». Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2009. http://hdl.handle.net/2108/876.
Texte intégralCD4(+)CD25(+) T regulatory (Treg) cells are a CD4(+) T cell subset involved in the control of the immune response. In vitro, murine CD4(+)CD25(+) Treg cells inhibit CD4(+)CD25(-) Th cell proliferation induced by anti-CD3 mAb in the presence of APCs. The addition of IL-4 to cocultured cells inhibits CD4(+)CD25(+) Treg cell-mediated suppression. Since all cell types used in the coculture express the IL-4Ralpha chain, we used different combinations of CD4(+)CD25(-) Th cells, CD4(+)CD25(+) Treg cells, and APCs from wild-type IL-4Ralpha(+/+) or knockout IL-4Ralpha(-/-) mice. Results show that the engagement of the IL-4Ralpha chain on CD4(+)CD25(-) Th cells renders these cells resistant to suppression. Moreover, the addition of IL-4 promotes proliferation of IL-4Ralpha(+/+)CD4(+)CD25(+) Treg cells, which preserve full suppressive competence. These findings support an essential role of IL-4 signaling for CD4(+)CD25(-) Th cell activation and indicate that IL-4-induced proliferation of CD4(+)CD25(+) Treg cells is compatible with their suppressive activity. The transfert of CD4(+)CD45RB(high) T cells from the spleen of normal mice to SCID recipient leads to the development of Th1-mediated colitis. CD4(+)CD45RB(low) Treg cells show to prevent the development of colitis. The transfert of CD4(+)CD45RB(high) T cells from spleen of IL-4Ralpha-/-mice leads to the development colitis less seriously than CD4(+)CD45RB(high) T cells from spleen of IL-4Ralpha+/+ mice.
Siu, Ada Hoi Ling. « Cardioprotective effects of herba cistanche on ischemia/reperfusion injury ex vivo and oxidative injury in vitro / ». View abstract or full-text, 2008. http://library.ust.hk/cgi/db/thesis.pl?BICH%202008%20SIU.
Texte intégralFocarelli, M. L. « GENERAZIONE DI CELLULE STAMINALI PLURIPOTENTI INDOTTE E LORO CORREZIONE IN VITRO IN UN MODELLO MURINO DI OSTEOPETROSI ». Doctoral thesis, Università degli Studi di Milano, 2014. http://hdl.handle.net/2434/231159.
Texte intégralCARROZZINI, TATIANA. « Nutrition interventions in aging : study of coffee-derived compounds antioxidant properties in an in vitro model of ischemia ». Doctoral thesis, Università degli Studi di Milano-Bicocca, 2021. http://hdl.handle.net/10281/309808.
Texte intégralNowadays, the people get older and older thanks to a better life-style, but consequently, carrying on pathologies typical of the old age, included aging. The aging is a complex physiological process and age-related changes are evident anatomically and physiologically in the BBB. The accumulation of oxidative damage to macromolecules by RONS and ROS in BBB can be crucial in the development and progression of different CNS pathologies. In this situation, cerebral ischemia could further alter the oxidant/antioxidant balance in favour of oxidants. In this scenario, nutrition can counteract the oxidative impacts, polyphenol-enriched diets can provide beneficial effects, preventing cognitive decline and degenerative disorders. More recently, coffee has been described as a very important source of antioxidant compounds (Ricci A. et al., 2018) but its production generates large amount of waste. According to these guidelines, the aim of this study was to evaluate the antioxidant properties of several coffee-related compounds alone and combined together in an in vitro model of ischemia. The compounds used were: phytoextracts deriving from the waste of coffee production and enriched in specific polyphenolic components; and coffee metabolites found in plasma of people drinking coffee. The moment after reoxygenation causes a considerable increase in ROS, reaching a maximum peak within 1 hour of the restoration of normal culture conditions (Adibhatla RM et al., 2001). Therefore, for the evaluation of the antioxidant properties after OGD, the time span 0-1h immediately following recovery was chosen as the condition of greatest stress. Therefore, in order to evaluate the antioxidant properties of the coffee compound under OGD, the antioxidant pathway Nrf2 was analyzed within 0-1h, immediately following recovery. Evaluations were performed on the state of phosphorylation of Erk and Akt kinases, which if active promote Nrf2 migration in the nucleus, on the levels of the Nrf2 protein and on its intracellular distribution, and finally on the protein levels of HO-1, as one of its genes target. Furthermore, the protein Hsp70, which is involved in the control of protein folding, was also evaluated. Finally, malondialdehyde (MDA) production was measured as a marker of lipid peroxidation 24 hours after recovery. The results suggested the ability of coffee-related compounds to activate the Nrf2 signaling pathway differently and only the pre-treatment with metabolites modulated positively Hsp70. MDA results suggested that the presence of the antioxidant compounds, tested alone or combined, had a positive effect on its modulation. The results showed the antioxidant properties of phytoextracts and specific coffee metabolites, suggesting that the substances stimulate the antioxidant response by activating different pathways, which combined together in the mix, could enhance antioxidant defense. The antioxidant effect of coffee metabolites could indicate that the moderate intake of coffee every day in elderly subjects exposed to aging and greater risk of ischemic insult, could contribute to the reduction of oxidative stress by limiting reperfusion damage in the case of ischemic attacks. These defenses could be increased through the phytoextracts derived from coffee ingested as food supplements. The reuse of this waste biomass, would have a positive impact on both the economy and the ecosystem, as it would significantly reduce pollution.
Chan, Pui-shan. « Effects of NPY-Y1 receptor activation or inhibition on free radical generation during in vitro or in vivo cerebral ischemia ». Click to view the E-thesis via HKUTO, 2006. http://sunzi.lib.hku.hk/hkuto/record/B35760825.
Texte intégralMARINO, ROSANNA. « La paratubercolosi bovina causata dal Mycobacterium avium subsp paratuberculosis : un modello in vitro per studiare la risposta precoce all'infezione ». Doctoral thesis, Università Cattolica del Sacro Cuore, 2013. http://hdl.handle.net/10280/2052.
Texte intégralJohne’s disease (paratuberculosis) is a chronic granulomatous enteritis caused by Mycobacterium avium subsp paratubercolosis (MAP), affecting ruminants worldwide with a significant economic impact. MAP has also been speculated as a cause of human Crohn’s disease. MAP is a pathogen highly adapted for survival within host macrophages due to the organism's capacity to prevent macrophage activation, block phagosome acidification and maturation, and attenuate presentation of antigens to the immune system. The consequence is a very long silent infection and subclinical phases. To decipher the complex interaction between host and MAP, the response of in vitro bovine monocyte-derived macrophages (MDM) after 2h, 6h and 24h of infection with L1 strain of MAP was explored using RNA-Seq approach. Statistical analysis of sequence data revealed an increasing number of differentially expressed genes in MDM following infection through the three time points analysed. Furthermore down-regulated genes were only found at 24 h post-infection. Ingenuity Pathways Analysis of differentially expressed genes showed that “cell-mediated immune response” was the most significant network related to 2hpi dataset, “immune cell trafficking” for 6hpi, and “inflammatory response” for 24hpi. Finally the analysis of down-regulated genes at 24hpi confirmed the role of complement and major histocompatibility complex (MHC) in the pathogenesis of MAP in cattle.
MAZZOLA, CHIARA. « La regolazione del metabolismo in un modello in vitro di astrocity corticali : un meccanismo Ca2+-dipendente o Ca2+-independente ? » Doctoral thesis, Università degli studi di Padova, 2022. http://hdl.handle.net/11577/3454110.
Texte intégralAstrocytes are glial cells located in the central nervous system. They play several important roles, including synaptic signalling, neurotransmitter synthesis and recycling, control of nutrient uptake and neuronal survival. Calcium homeostasis is essential for astrocytes functions and for the correct bidirectional communication between astrocytes and neurons. Astrocytes are functionally compartmentalized, and calcium oscillations can occur in specific local microdomains. A change in astrocytic calcium microdomain activity influences the regulation of gliotransmitter release, a first crucial step in neuron to astrocytes signalling. In this context, mitochondria could play a pivotal role in shaping calcium waves and regulating cellular metabolism, at least in principle. However, the genuine contribution of mitochondrial calcium to astrocytes physiology is poorly investigated. Here, we study a possible link between mitochondrial calcium and metabolism. Our results show that star-shaped astrocytes represent a reasonable in vitro model for studying Ca2+ signalling and metabolic pathways. In our culture condition, astrocytes are metabolically flexible, being able to oxidize carbohydrates, fatty acids and amino acids. Thus, this supports the central role played by astrocytes in satisfying the brain energy demands. Indeed, in terms of Ca2+ signalling, ATP and glutamate cause similar cytosolic Ca2+ mobilization, but only ATP stimulates a consintent rise in [Ca2+] in mitochondrial matrix. Moreover, these stimuli are decoded differently at metabolic level. On the one hand, cellular stimulation with ATP selectively increases cytosolic glycolytic metabolism. On the other hand, cellular stimulation with glutamate boosts mitochondrial respiration, even in the absence of substantial mitochondrial Ca2+ uptake. To investigate the mechanisms underlying this different metabolic coupling, we evaluated the contribution of the glutamate transporters GLT-1 and GLAST, and showed that their pharmacological inhibition partially prevents the increase in mitochondrial respiration, but with limited impact on calcium dynamics. To further dissect the contribution of mitochondrial Ca2+ uptake to astrocytic metabolism, we devised two different strategies, one based on the pharmacological inhibition of the MCU (Mitochondrial Calcium Uniporter) complex, and the other based on the use of a mouse model carrying the monoallelic deletion of Mcu gene. Experiments performed in cortical astrocytes from Mcu+/- mice showed, as expected, lower mitochondrial calcium transients, but without major alterations in oxidative metabolism, suggesting a marginal role for matrix calcium elevations in this context. Overall, our results suggest that the astrocytes are cells with a complex and flexible metabolic profile. However, cellular and mitochondrial calcium dynamics play a minor role in this regulation, at least in our experimental settings.
Giedt, Randy James. « Real-Time Acquisition and Analysis of Endothelial Mitochondrial Superoxide Radical Production and Membrane Potential During In Vitro Ischemia/Reperfusion ». The Ohio State University, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=osu1243541457.
Texte intégralChan, Pui-shan, et 陳佩珊. « Effects of NPY-Y1 receptor activation or inhibition on free radical generation during in vitro or in vivo cerebral ischemia ». Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2006. http://hub.hku.hk/bib/B35760825.
Texte intégralWang, Jie. « The Study of the Effects of (1S,2E,4R,6R,-7E,11E)-2,7,11-cembratriene-4,6-diol on Microglia Polarization Using an Ischemia in Vitro Model ». University of Cincinnati / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1491559717910191.
Texte intégralTjong, Yung-wui, et 鍾勇會. « Mechanisms of endogenous nitric oxide production and intracellular pathways in rat hippocampal CA1 calcium response to hypoxia and in-vitro ischemia ». Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B30073005.
Texte intégralVelly, Lionel. « Effets neuroprotecteurs des agents anesthésiques sur des modèles in vitro et in vivo d'ischémie cérébrale ». Thesis, Aix-Marseille 2, 2010. http://www.theses.fr/2010AIX22957/document.
Texte intégralThe neuroprotective effect of anesthetic agents is now established for over 30 years.However, the mechanisms involved remains to be fully explored. This work focuses on twoneuroprotective strategies:The first part is on the involvement of glutamatergic transmission in their directneuroprotective effects. We studied the effect of two separate classes of anesthetic agents:propofol and sevoflurane on co-cultures of cortical neurons and astrocytes from rats subjectedto a transient oxygen and glucose deprivation (OGD) mimicking cerebral ischemia. Weobserved that the presence of propofol or sevoflurane during OGD prevented neuronal death,accumulation of extracellular glutamate and decreased uptake of glutamate induced byischemia. We also demonstrated that this partial restoration of glutamate uptake mediated bypropofol and sevoflurane involved differential transporters.The second part deals with the neuroprotection achieved by pharmacologicalpreconditioning with regard to the use of volatile anesthetic agents before ischemia. We firstconfirmed in vitro the existence of such protection with sevoflurane. We also highlighted therole of ATP-dependent potassium channels and reactive oxygen species in sevofluranepreconditioning-induced neuroprotection. Then, using an in vivo model of focal transientischemia, we showed that sevoflurane preconditioning significantly improved functionaloutcome and reduced infarct volume. However, this protection was transient. Sevofluraneonly delayed the neuronal death associated with apoptosis but offers an interesting therapeuticwindow
Bellini, Luca. « Effetto degli oppioidi sulle cellule di tubulo renale prossimale : studio in vitro e possibili applicazioni ». Doctoral thesis, Università degli studi di Padova, 2010. http://hdl.handle.net/11577/3426879.
Texte intégralGli analgesici oppioidi sono ampiamente usati in medicina. Questa classe di farmaci, oltre ad una azione sul sistema nervoso, ha effetti anche a livello di tessuti periferici dove i recettori oppioidi vengono espressi. Negli ultimi anni diversi studi mostrano come il precondizionamento con oppioidi abbia effetti protettivi contro i danni dovuti a ischemia e riperfusione che si presentano inevitabilmente durante un trapianto d’organo. Lo scopo del lavoro è quello di valutare l’effetto su una linea cellulare derivante da tubulo renale prossimale che esprime i recettori κ degli oppioidi, sottoposta o meno ad un evento ischemico. Le cellule OK (Opossum Kidney tubular cells) sono state esposte a 4 oppioidi (morfina, fentanyl, butorfanolo e buprenorfina) alle concentrazioni di 10-10, 10-8, 10-5 M. Le cellule erano: 1) esposte ai farmaci per 48 ore; 2) esposte agli analgesici prima e dopo un evento ischemico indotto con antimicina A e 2-Deossi-D-glucosio od ancora trattate con i farmaci solo prima o solamente dopo. Sono state eseguite prove colorimetriche e di luminescenza per valutare la vitalità cellulare, il contenuto di ATP e attivazione delle caspasi-3 e -7. Prove citofluorimetriche erano impiegate per valutare l’apoptosi e la necrosi. Ad alte dosi fentanyl e buprenorfina dimiuiscono la sopravvivenza delle cellule OK dopo 48 ore di esposizione ma l’effetto è limitato e non rilevante. La morfina e il fentanyl hanno un effetto positivo nel preservare il contenuto di ATP e nel diminuire l’attivazione delle caspasi e l’apoptosi. anche la necrosi diminuisce quando le cellule sono esposte a questi oppioidi prima e dopo l’evento ischemico. Il fentanyl mantiene elevato l’ATP anche quando somministrato prima dell’evento ischemico. Butorfanolo e buprenorfina non mostrano alcun effetto positivo sul contenuto di ATP o sull’apoptosi. Gli agonisti puri dei recettori degli oppioidi κ prevengono la comparsa di apoptosi e necrosi preservando il contenuto cellulare di ATP dopo ischemia. Il loro impiego potrebbe dimostrare dei vantaggi nel prevenire i danni da ischemia e riperfusione durante interventi di trapianto renale.
CERQUENI, GIORGIA. « In vitro strategies and development of bioengineered approaches for studying age-related osteochondral diseases ». Doctoral thesis, Università Politecnica delle Marche, 2021. http://hdl.handle.net/11566/292220.
Texte intégralLo scopo di questo progetto di dottorato è lo sviluppo di modelli di coltura in-vitro per studiare diversi aspetti dell'osteoartrosi (OA), una malattia degenerativa che coinvolge tutti i tessuti dell’articolazione tra cui la cartilagine articolare, la membrana sinoviale e l'osso subcondrale. L'incidenza globale dell'OA del ginocchio è di 203 per 10.000 persone all’anno e cresce con l'aumentare dell'età, raggiungendo un picco tra i 70-79 anni. Il principale sintomo disabilitante dell'OA è il dolore, tipicamente intermittente e portante (meccanico) che può, in alcuni casi, a stress psicologico. Contrariamente alla comune descrizione di una patologia correlata all'usura, l'OA è la conseguenza di un processo attivo e sbilanciato di riparazione e distruzione. Le cause che portano all’insorgenza di tale patologia non sono ancora state del tutto identificate e si dibatte ancora sull'ordine preciso degli eventi coinvolti nella sua progressione. Attualmente, la scarsa conoscenza della patogenesi dell’OA e le numerose modificazioni tissutali che la caratterizzano hanno reso complicato lo sviluppo di un modello in-vitro. È quindi necessario comprendere i meccanismi coinvolti nella progressione della patologia, nonché i target di nuovi trattamenti per il ripristino della funzionalità articolare. Qui, due diversi modelli di coltura in-vitro per indagare diversi aspetti dell'OA: (i) il coinvolgimento di cellule staminali / stromali adulte della membrana sinoviale nel rimodellamento osseo, attraverso un approccio di co-coltura 2D indiretta e (ii) il crosstalk tra condrociti e osso subcondrale in condizioni normali e patologiche, sviluppando uno scaffold 3D ingegnerizzato e simulando un microambiente infiammato. Questi due modelli hanno permesso lo studio dei comportamenti cellulari di tre tessuti coinvolti nella patogenesi dell'OA e lo sviluppo di una possibile piattaforma in-vitro per futuri studi che potranno comprendere simultaneamente queste tre componenti.
Konrath, Eduardo Luis. « Investigação in vitro do efeito neurotóxico, antioxidante e anticolinesterásico de alcalóides e avaliação de parâmetros de estresse oxidativo em fatias de hipocampo submetidas à privação de oxigênio e glicose ». reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2006. http://hdl.handle.net/10183/7868.
Texte intégralNeurodegenerative disorders, such as Alzheimer, Parkinson and cerebrovascular diseases are one of the major causes of morbidity and mortality in the middle aged and the elderly. Also, the imbalance between the activity of free radicals generation and scavenging systems, called oxidative stress, plays a important role in the neuronal damages caused by ischemia, leading to functional alterations in macromolecules and promoting lipoperoxidation in membranes. Acetylcholinesterase inhibitors and antioxidant compounds have been extensively investigated as new pharmacological strategies for the symptomatic treatment of Alzheimer disease. In this way, natural products are potentially important in an attempt to develope newer and safer drugs. In the present study, we selected the in vitro model of oxygen and glucose deprivation (OGD) in hippocampal slices and the methods used to assess the neurotoxicity of the alkaloids were cellular lactate dehydrogenase (LDH) release and reduction of MTT salt (mitochondrial activity). Both alkaloids boldine and vincamine 100 μM promoted a 40 % increase in LDH release in POG slices, as well as significant increases in the activity of this enzyme in control slices. Psychollatine and reserpine had also neurotoxic effects. It was also verified that OGD decreased the measurements of total antioxidant potential (TRAP) in 63 % and the total antioxidant reactivity (TAR) levels in 16.5 %, as well as an increase in the malondialdehyde levels by slices, which was detected by thiobarbituric acid-reactive substances (TBA-RS). However, this effect was prevented by the presence of boldine 10 μM and 50 μM. This alkaloid is a known antioxidant and it displayed a potent scavenger activity for peroxyl radicals, when compared with Trolox. Another finding is that the monoterpene indole alkaloids coronaridine, venalstonine, andrangine, vincadifformine, voacristine and also boldine exhibited both potent antioxidant and acetylcholinesterase inhibitor activities in in vitro autobiographic assays.
Rizzo, F. « GENERAZIONE DI IPSC COME MODELLO IN VITRO E SVILUPPO DI UN POSSIBILE APPROCCIO TERAPEUTICO PER LA MALATTIA DI CHARCHOT-MARIE-TOOTH DI TIPO 2A(CMT2A) ». Doctoral thesis, Università degli Studi di Milano, 2015. http://hdl.handle.net/2434/249995.
Texte intégralGrisafi, Davide. « Possibile impiego delle cellule staminali del fluido amniotico per la riparazione del danno polmonare in un modello animale per broncodiplasia : valutazione in vitro e in vivo ». Doctoral thesis, Università degli studi di Padova, 2008. http://hdl.handle.net/11577/3426276.
Texte intégralSánchez, Opazo Guillem. « Estudi dels mecanismes de mort cel·lular induïts per un model d’isquèmia cerebral in vitro : implicació dels antagonistes dels receptors de mortJosé Rodríguez Álvarez ». Doctoral thesis, Universitat Autònoma de Barcelona, 2014. http://hdl.handle.net/10803/284058.
Texte intégralStroke is the second cause of death in industrialized countries and is the leading cause of disability in adults. The only currently approved treatment is the thrombolytic tissue plasminogen activator (tPA), which can be applied only in a very small number of patients and within a narrow therapeutic window. The mechanisms of cell death in brain ischemia are numerous and are caused by the interruption of the blood flow to the brain, which causes a quick necrotic death in the core of the affected area and a slow apoptotic-like death around, in the ischemic penumbra. The major socio-economic impact of the disease and the existence of a programmed cell death that stretches through time explain the effort that is being done to find new strategies to save the penumbra. Given these facts, the present work has focused on studying the mechanisms of cell death involved in brain ischemia. To do this, we used a model of oxygen and glucose deprivation (OGD) in mixed cortical cultures from rat embryos. Using this model of ischemia we observed neuroprotection by blocking NMDA receptor, the primarily responsible for the massive influx of calcium during ischemia, and activation of caspase-3, a protease responsible for dismantling the cell during apoptosis. In addition, we studied the role of death receptor antagonists in OGD. These receptors are responsible for the activation of the extrinsic apoptotic pathway. It has been observed that OGD induces degradation of the antagonists FLIPL and IAP2 and modulate the expression of FAIML through the MAP kinase pathway. On the other hand, we observed that the overexpression or silencing of FAIML using lentiviral vectors did not affect the viability of the cultures nor the apoptotic nuclear morphology or the levels of active caspase-3 in the neurons subjected to the ischemic insult. Together these results have served to study the molecular mechanisms involved in brain ischemia and may provide the basis for future studies that will help to design new therapeutic strategies.
Lübbe, Katharina. « Entwicklung und Einsatz eines In-vitro-Ischämiemodels zur Untersuchung zellulärer Pathomechanismen der Klauenrehe des Rindes ». Doctoral thesis, Universitätsbibliothek Leipzig, 2015. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-171594.
Texte intégralThe subclinical laminitis or claw horn disruption (CHD) is of great economic importance in the dairy industry as it causes lameness, poor general condition and reduced performance. Despite extensive research efforts, the pathomechanism of CHD remains widely unclear. The current hypotheses on CHD pathogenesis include ischemic alterations of the epidermal keratinocytes resulting from an impaired blood supply. This causes an alteration of cell proliferation, a dermo-epidermal separation and an impaired keratinization and horn production. Therefore, in vitro ischemia models are of critical importance in clarification of the epidermal responses to an altered microcirculation. The aim of this study was the establishment of an in vitro ischemia model based on bovine claw keratinocytes. This in vitro model should enable the investigation of cellular pathomechanisms following exposure to ischemia, hypoxia and glucose deprivation. An additional aim was the analysis of the differentiation pattern of keratinocytes under ischemic, hypoxic and hypoglycaemic conditions. To establish the in vitro ischemia model, the keratinocytes were exposed to oxygen-glucose deprivation (OGD). In addition, this model allowed the parallel examination of hypoxic and hypoglycaemic conditions on bovine claw keratinocytes. The experiments were divided into a short-term analysis over 96h and a long-term analysis over three weeks. Measurement of cell viability was performed by LDH(lactatedehydrogenase) and MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra- zolium bromide) assays. Furthermore, the differentiation pattern of the keratinocytes after exposure to ischemia, hypoxia and glucose deprivation was detected by western blot analysis of the focus on expression of involucrin and loricrin. The highest cytotoxic effect was measured after short exposure to OGD followed by a time-dependent decrease of cell viability and extensive morphological changes of the keratinocytes. Hypoxic conditions lead to a time-dependent decrease of cell viability with the highest cytotoxicity after two weeks. The keratinocytes showed slight changes in cell morphology while maintaining a confluent cell layer. Exposure of keratinocytes to glucose deprivation showed a high decrease of cell viability and strong morphological changes. Furthermore, western blot analysis showed an altered expression pattern with increased involucrin and loricrin levels after exposure to OGD, hypoxia and glucose deprivation. The present study established for the first time an in vitro ischemia model based on bovine claw keratinocytes to study the cellular mechanisms of the epidermis. After exposure to OGD, keratinocytes showed the highest loss in cell viability and an altered cell differentiation. This reflects the pathophysiological changes following epidermal ischemia occurring during the pathogenesis of CHD. The massive cellular alterations after glucose deprivation provide good evidence for the importance of glucose in the cellular metabolism of keratinocytes. An epidermal glucose deficiency may occur in combination with a negative energy balance during peripartal period in cattle. The results of hypoxia show the different adaptive mechanisms of keratinocytes to hypoxic conditions which are present in the epidermis during cell differentiation. Thus, the in vitro ischemia model has a great potential for use in research into CHD pathogenesis and pathomechanisms associated with ischemia. On one side, it is possible to investigate the pathological changes following ischemia during CHD. On the other side, the model offers useful information on physiological response mechanisms of the epidermis that correlate with cell differentiation
RAGAZZINI, GREGORIO. « Meccanobiologia di sistemi biologici : da doppi strati lipidici a cellule in-vitro ». Doctoral thesis, Università degli studi di Modena e Reggio Emilia, 2021. http://hdl.handle.net/11380/1250708.
Texte intégralMechanical properties of biological systems play a crucial role for their own behavior. As an example, many potential drugs could modify mechanical properties of the biological membrane and indirectly modulate transmembrane protein functions. Similarly, many pathological conditions at the cellular level are characterized by a phenotype with altered mechanical properties, and these alterations are due to cytoskeleton reorganization. At the same time, cells continuously probe rheological properties of extracellular matrix (ECM) enabling, depending on response obtained by the substrate, different downstream signaling cascades. In many cases, cytoskeleton reorganization occurs also when cells are experiencing periodic mechanical stimuli, as it happens for example in the cardiovascular system or in lungs. All these aspects are treated by a recent branch of physic and biology sciences: “Mechano-biology”. This PhD thesis work has been devoted to study some specific aspects of mechanical properties of biological systems: from simple models of the biological-membrane, like supported-lipid-bilayer (SLB) or giant-unilamellar-vescicle (GUV), to in-vitro cells. Investigation techniques exploited in this work include: phase-contrast optical microscopy, DIC and fluorescence microscopy and atomic force microscopy (AFM). In the thesis we developed analysis-methods and devices dedicated to specific application and measurements of biological samples. It has been designed, tested and employed successfully an on-stage cell incubator for live cell imaging. From time-lapse microscopy experiments we obtained different quantitative migration parameters both for cell exposed to different drugs and for cells seeded on substrates with different mechanical rigidity. The same cell incubator has been modified to include an uniaxial stretcher, able to provide specific periodic deformation functions to the substrate on which cells are growing, and we studied the effect of the periodic stimulation on cell migration and polarization. Among the different analysis methods, a single cell migration analysis protocol has been developed, exploiting the “Persistence-Random-Walk” model. The ultimate goal was that of analyzing the cytostatic effect of a potential drug for U87MG cell line, employed as model of the glioblastoma multiforme disease. The analysis has in fact shown the efficiency of this molecule for both migration and replication of this cell line. Furthermore, possible biochemical mechanisms of action involved in these effects have been investigated. In the context of SLBs and GUVs a line tension analysis of domains recapitulating lipid-raft and a bending constant measurement have been implemented, both based on Flickering spectroscopy theory. In the former case, line tension results of ternary mixture containing different components relevant for lipid-rafts formation have been compared for different lipid compositions. In the latter case, the role of exogenous molecules (antimicrobial peptides and lipopeptides) on the bending constant has been investigated. In viscoelastic characterization of the cell cytoskeleton through AFM, a Ting model-based software has been implemented, allowing to extrapolate viscoelastic parameters from single indentation-retraction curves. Using this method, the effect of the previously mentioned potential drug has been investigated, trying to correlate rheological properties to migration capabilities of U87MG. Finally, software dedicated to Jump-Through-Force curves by AFM to identify specific events on SLB, and tether pulling events during AFM tip retraction on plasma-membrane have been developed; in order to find possible methods to highlight variations in rheological properties of membrane exposed to different drug treatments.
Dal, Pozzo Fabiana <1978>. « Virus animali come modello nello studio in vitro dell'attività di molecole antivirali : applicazioni future in medicina veterinaria e nei confronti di virus filogeneticamente correlati responsabili di patologie umane ». Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2007. http://amsdottorato.unibo.it/531/1/dal_pozzo_fabiana_tesi.pdf.
Texte intégralDal, Pozzo Fabiana <1978>. « Virus animali come modello nello studio in vitro dell'attività di molecole antivirali : applicazioni future in medicina veterinaria e nei confronti di virus filogeneticamente correlati responsabili di patologie umane ». Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2007. http://amsdottorato.unibo.it/531/.
Texte intégralLübbe, Katharina [Verfasser], Christoph K. W. [Akademischer Betreuer] Mülling et Alois [Gutachter] Boos. « Entwicklung und Einsatz eines In-vitro-Ischämiemodels zur Untersuchung zellulärer Pathomechanismen der Klauenrehe des Rindes : Development and experimental application of an in vitro ischemia model for investigating the cellular pathomechanism of laminitis in cattle / Katharina Lübbe ; Gutachter : Alois Boos ; Betreuer : Christoph K.W. Mülling ». Leipzig : Universitätsbibliothek Leipzig, 2015. http://d-nb.info/1239566565/34.
Texte intégralComajoan, von Arend Pau. « Efecte de l'administració de l'rt-PA en condicions isquèmiques in vitro i in vivo : Cav-1 com a potencial biomarcador de volum d'infart ». Doctoral thesis, Universitat de Girona, 2019. http://hdl.handle.net/10803/669184.
Texte intégralL'rt-PA és l’únic fàrmac aprovat per tractar l’ictus isquèmic agut. No obstant, l’estreta finestra terapèutica, deguda al risc associat de transformació hemorràgica (TH) provoca que només s’apliqui a <5-7% dels pacients. La TH està relacionada amb la disrupció de la barrera hematoencefàlica (BHE) deguda a l’rt-PA però els mecanismes subjacents encara no estan del tot establerts. Els resultats obtinguts mostren que es requereixen estudis a llarg termini per tal de dilucidar els mecanismes dependents del temps associats a la disrupció de la BHE, i explorar noves teràpies protectores per al tractament de l’ictus isquèmic. S’ha demostrat que la POG provoca canvis significatius en els nivells proteics de controls de càrrega per “Western blot” i es presenta la tecnologia “Stain-Free” com a una alternativa a la normalització tradicional. Finalment, els nivells sèrics de Cav-1 podrien representar un potencial biomarcador predictor del pronòstic després d’una isquèmia en absència d’rt-PA
S'ha extret el capítol de resultats del pdf de la tesi fins a la seva publicació en forma d'article. Results chapter removed from pdf file until publication
Poizat, Adrien. « Contrôle temporel de la cavitation ultrasonore : application à la thrombolyse ultrasonore extracorporelle ». Thesis, Lyon, 2016. http://www.theses.fr/2016LYSE1031/document.
Texte intégralFocused ultrasound can be used for therapeutic applications in the human body. In cardiovascular applications, they can destroy blood clots formed in the vascular system. In this case, thrombolysis mechanisms are related to ultrasonic cavitation, but the complex dynamics remains an obstacle to the development of a therapeutic device. In this thesis, a system for the temporal control of the pulsed cavitation activity has been developed and characterized. This device uses a focused transducer and a hydrophone with a feedback loop for regulating the cavitation activity. While cavitation activity has a random behaviour in non-regulated conditions, the control system developed achieves a desired level of cavitation with very reproducibly and with good temporal stability. The application of this device to the ultrasound thrombolysis was tested in vitro on human blood clots. In the previous device was added a system for moving the blood clot at the focal point, and a tube for counting the number of fragments released by the destruction of the clot. In comparison to uncontrolled regime, tests showed an excellent thrombolytic efficacy and a very good reproducibility, with reduced acoustic intensities. In parallel to the in vitro tests, ultrasound thrombolysis was tested in vivo on an animal model of acute limb ischemia. An extracorporeal ultrasound device, guided by ultrasound and mounted on a robotic arm, has been developed for in vivo investigation. An ovine model of arterial thrombosis has also been developed. Tests were used to validate the feasibility of the model of arterial clots and to validate in vivo the concept of purely ultrasonic extracorporeal thrombolysis based on inertial cavitation regulation system
Grillo, Doriana Maria. « La CFD nei meandri della digestione gastrica : fluidodinamica computazionale del contenuto gastrico ». Bachelor's thesis, Alma Mater Studiorum - Università di Bologna, 2021.
Trouver le texte intégralCassien, Mathieu. « Etudes in vitro/in vivo de la toxicité de polluants atmosphériques. Implication du stress oxydant dans les mécanismes génotoxiques et sur la variation des paramètres biochimiques ». Thesis, Aix-Marseille, 2016. http://www.theses.fr/2016AIXM4703.
Texte intégralEpidemiological studies have consistently reported that particulate matter in ambient air pollution is associated with increases in cardiopulmonary diseases and mortality. Because they can deeply penetrate lung tissue, reaching blood stream and organs, nanoparticles (NPs) are considered particularly harmful. Here, our foray into the specific mutagenicity and cytotoxicity of NPs focused on manufactured nano-CeO2 (a fuel additive) and NPs known to form in air from a variety of atmospheric toxicants (eg, combustion residues, pesticides). We first revealed a genotoxic effect of nanoCeO2 on human fibroblasts by a clastogenic mechanism following stimulation of the release of O2•-/H2O2 by NADPH oxidase and mitochondria. However, upon exposure of these cells to nM doses of 1-nitropyrene (a combustion byproduct) promotion of DNA damage involving an aneugenic mechanism occurred before a clastogenic effect was seen at µM doses. Second, using a home-made chamber equipped with an aerosol generator, we determined indices of oxidative stress and tissue damage in rats chronically inhaling toxicant NPs for 1-5 months at environmentally relevant doses. Long term exposure, even at low NPs doses, provoked systemic oxidative stress, lipid peroxidation, kidney damage, liver dysfunction, changes in lipid profile and occurrence of disorders of glucose tolerance. Moreover, a strong impairment of hemodynamic performance was evidenced in hearts from NP-exposed rats. By extending literature data of the in vitro toxicity of NPs to the in vivo situation, our study incriminates the nano-sized components of atmospheric particulate matter as a privileged vector of genotoxicity and cardiotoxicity
Mazzei, Cinzia, et Giacinto Bagetta. « Ruolo del sistema endocannabinoide nei meccanismi di neuroprotezione da 17β-estradiolo in un modello sperimentale di ischemia cerebrale focale ». Thesis, 2013. http://hdl.handle.net/10955/336.
Texte intégralIn questo studio sono stati determinati i livelli endogeni dell’endocannabinoide finora meglio caratterizzato, anandamide (AEA) e l’attività degli enzimi responsabili, rispettivamente, della sua sintesi e degradazione, la NAPE-PLD e la FAAH, nella corteccia e nello striato di ratti sottoposti ad occlusione dell’arteria cerebrale media (MCAo) di 2 ore. È stato osservato che il contenuto di AEA nello striato di ratti sottoposti a MCAo, ma non nella corteccia, era significativamente incrementato (all’incirca di 3 volte rispetto ai ratti controllo, P < 0.01) e questo incremento era accompagnato parallelamente da un aumentata attività della NAPE-PLD (di circa 1.7 volte rispetto ai ratti controllo, P < 0.01) e da una ridotta attività (~ 0.6 volte; P<0.05) ed espressione della FAAH (~0.7 volte; P< 0.05). Questi effetti indotti dalla MCAo venivano ulteriormente potenziati da un ora di riperfusione, mentre il legame dell’AEA al recettore cannabinoide CB1 e al recettore vanilloide TRPV1 non erano influenzati in maniera significativa dall’insulto ischemico. Inoltre, il trattamento con l’antagonista del recettore CB1, SR141716, e non quello con l’agonista R-(+)- WIN55,212-2, ha dimostrato di ridurre significativamente (33%; P<0.05) il volume cerebrale d’infarto dopo 22 ore di riperfusione; mentre la somministrazione di una dose neuroprotettiva di 17β-estradiolo (0.20 mg/kg, i.p.), che era in grado di ridurre il volume d’infarto del 43%, si dimostrava capace anche di ridurre l’effetto dell’ischemia cerebrale sul sistema endocannabinoide in maniera recettore estrogenico dipendente. In conclusione, abbiamo dimostrato che il sistema endocannabinoide è implicato nella fisiopatologia del danno cerebrale tMCAo indotto e che la modulazione farmacologica di questo sistema endogeno da parte dell’estradiolo conferisce neuroprotezione.
Università della calabria
Petrelli, Francesco, Diego Sisci et Diana Amantea. « Cratterizzazione degli effetti neuroprotettivi della leptina in un modello sperimentale di ischemia cerebrale focale nel ratto ». Thesis, 2011. http://hdl.handle.net/10955/1026.
Texte intégralLa leptina, oltre ad avere effetti sull’ipotalamo per il controllo del peso corporeo, è coinvolta nella regolazione della funzionalità, dello sviluppo e della sopravvivenza neuronale. Studi recenti hanno evidenziato i suoi effetti neuroprotettivi nel danno ischemico cerebrale, ma fino ad oggi il ruolo del fattore di trasduzione ed attivatore trascrizionale (STAT)-3, il principale mediatore della via di trasduzione del segnale di ObR nel cervello, non è stato chiarito. I nostri dati dimostrano che la somministrazione sistemica acuta di leptina è neuroprotettiva in ratti sottoposti ad occlusione permanente dell’arteria cerebrale media (MCAo), come documentato dalla riduzione significativa del volume di infarto cerebrale e del deficit neurologico fino a 7 giorni dopo l’induzione di ischemia. Mediante analisi di immunofluorescenza e tecniche di frazionamento subcellulare abbiamo osservato che la neuroprotezione da leptina è associata con la modulazione dei livelli di fosforilazione di STAT-3 in differenti tipi cellulari nella corteccia cerebrale ischemica. Infatti, poche ore dopo l’insulto la leptina aumenta i livelli di p-STAT3 nel nucleo degli astrociti della penombra ischemica contribuendo così agli effetti benefici di queste cellule sull’evoluzione del danno. L’aumentata espressione di homer-1a che osserviamo negli astrociti fino a 7 giorni dopo l’induzione di ischemia, sottolinea ulteriormente il loro ruolo benefico. Mediante ricostruzione 3D di immagini di microscopia elettronica, combinata con analisi morfometrica, abbiamo osservato che gli astrociti reattivi mostrano un ridotto coverage bilaterale, mentre la percentuale di contatto con le sinapsi glutammatergiche rimane invariata. Inoltre, l’aumento di p-STAT3 indotto dalla leptina nei neuroni dopo 24h di MCAo è associato con un aumento dell’espressione dell’inibitore tissutale delle metalloproteasi della matrice (TIMP)-1 nella corteccia, suggerendo un suo coinvolgimento nella neuroprotezione indotta dall’adipochina
Università degli Studi della Calabria
Fernandes, Joana Filipa Coelho. « In vitro ischemia-induced changes in the transcriptome of hippocampal neurons : neuroprotective pathways in brain ischemia ». Doctoral thesis, 2014. http://hdl.handle.net/10316/25227.
Texte intégralA isquémia cerebral global devido à interrupção do fluxo sanguíneo no cérebro leva à privação de oxigénio e glicose nas células, reduzindo a energia disponível para manutenção do funcionamento celular. Os neurónios são especialmente sensíveis a esta falha energética, o que pode levar à activação de vias moleculares de morte celular. A região CA1 do hipocampo é particularmente vulnerável à isquémia global. Contudo, os sinais de morte celular surgem apenas horas ou dias após o insulto, criando uma janela temporal na qual podem ser aplicadas estratégias terapêuticas com vista à diminuição dos danos neurológicos causados pelo insulto. Pensa-se que este intervalo se deve a modificações transcripcionais que podem promover a sobrevivência ou a morte neuronal. No entanto, apesar do trabalho desenvolvido na identificação de genes cuja expressão está alterada após a isquémia global, os mecanismos responsáveis pela vulnerabilidade dos neurónios do hipocampo continuam por esclarecer. Assim, este trabalho teve como objectivo a identificação de mecanismos moleculares diferentemente regulados em culturas primárias de neurónios do hipocampo submetidos a um modelo in vitro para a isquémia global, a privação de oxigénio e glicose (do inglês, oxygen and glucose deprivation – OGD). Começámos por estabelecer o protocolo para análise da expressão genética usando este modelo. Verificámos que o estímulo de OGD induz um aumento na morte celular em função da duração do insulto, e que esta é significativa 24h após o estímulo, mostrando que este modelo induz morte celular retardada. Utilizando antagonistas selectivos para os receptores de glutamato do tipo AMPA e NMDA vimos que o bloqueio destes receptores teve um efeito neuroprotector, confirmando o seu papel na componente excitotóxica da morte por OGD. Vimos ainda a activação de calpaínas, proteases ligadas a vias de morte celular. De seguida investigámos as alterações no transcriptoma dos neurónios do hipocampo submetidos a OGD utilizando microarrays. Para isso, o RNA total das células foi extraído 7h e 24h após o estímulo com o objectivo de identificar genes envolvidos na resposta imediata e mais tardia à isquémia. Vimos que às 7h após OGD há uma maior repressão, enquanto 24h após o insulto há uma maior indução, na expressão de genes. A análise da ontologia genética mostrou que genes relacionados com stress oxidativo, metabolismo, apoptose, sinapse e actividade de canais iónicos apresentam diferentes níveis de expressão após OGD. Tanto quanto sabemos, este é o primeiro estudo a combinar microarrays e OGD como ferramenta para estudar alterações no perfil genético de neurónios do hipocampo a diferentes tempos de recuperação. Os resultados obtidos nos microarrays foram validados através da análise de qPCR para genes selecionados, pertencentes a diferentes grupos ontológicos. Observámos também que vários genes codificantes para proteínas da sinapse apresentaram diminuição na sua expressão em neurónios submetidos a OGD, bem como um aumento dos níveis de REST, um factor de transcrição que reprime a expressão de genes codificantes de proteínas neuronais sinápticas, como alguns dos que apresentam diminuição da expressão após OGD. Vimos ainda que este estímulo provoca a diminuição nos níveis de mRNA e proteína da subunidade GluA1 dos receptores AMPA, bem como das subunidades GluN2A e GluN2B e o aumento dos níveis de mRNA da subunidade GluN3A dos receptores NMDA, o que pode levar à alteração da composição destes receptores em neurónios do hipocampo. Estes resultados sugerem que o estímulo de OGD leva à activação de um programa transcripcional que causa uma repressão da expressão de proteínas sinápticas. Por fim, investigámos os níveis de expressão de genes codificantes para canais iónicos e, nomeadamente, a contribuição do canal de cloreto CLIC1 para a morte induzida por OGD, uma vez que o mRNA do CLIC1 está aumentado em neurónios submetidos a OGD. O papel do CLIC1 em neurónios é desconhecido, embora se pense que a activação deste canal em micróglia leva à morte de neurónios em condições tóxicas. Contudo, os nossos resultados mostram que a sobre-expressão do CLIC1 torna os neurónios menos vulneráveis ao dano induzido por OGD, e resultados preliminares sugerem que a expressão do CLIC1 pode estar aumentada em regiões do hipocampo mais resistentes à isquémia global. Os nossos resultados sugerem que o CLIC1 faz parte de um mecanismo intrínseco de protecção activado em neurónios após o insulto isquémico. Os resultados obtidos caracterizam o perfil global de expressão genética induzido por OGD em neurónios do hipocampo, permitindo o estudo de dois mecanismos distintos que podem contribuir para a sobrevivência neuronal: a diminuição da expressão de componentes sinápticos, nomeadamente dos que estão envolvidos na excitotoxicidade, e o aumento na expressão do CLIC1. Estes mecanismos podem ser explorados no sentido de desenvolver estratégias terapêuticas para o tratamento da isquémia cerebral.
Cerebral global ischemia due to interruption of blood supply to the brain results in oxygen and glucose deprivation of brain cells, reducing the energy available to maintain normal cellular functions. Neurons are especially sensitive to this energetic insufficiency and consequently fail to maintain the ionic gradients necessary for cellular function and homeostasis, which ultimately leads to the activation of several molecular pathways that impair neuronal function or may lead to cell death. The neurons of the CA1 region of the hippocampus are particularly vulnerable to global ischemia. However, signs of cell death arise only hours to days after the insult, providing a temporal window in which therapeutical approaches to prevent the delayed neurological and cognitive deficits triggered by ischemia can be employed. This delay is thought to include transcriptional changes that can either prime cell survival or enhance neuronal death. However, despite the effort to identify genes differently expressed after ischemia, the mechanisms responsible for the selective vulnerability of hippocampal neurons to global ischemia remain elusive. As such, the present work was aimed at investigating which transcription-dependent molecular mechanisms are differently regulated in hippocampal neuronal cultures subjected to oxygen and glucose deprivation (OGD), an in vitro model for cerebral global ischemia. Initially, we established the experimental set-up for the analysis of gene expression in this model. We observed an increase in OGD-induced neuronal death as a function of OGD time length, but neuronal death was only significant 24h after the stimulus, showing that OGD induced delayed neuronal death. Selective antagonists of the AMPA and NMDA glutamate receptors were neuroprotective, confirming the contribution of these receptors to the excitotoxic component of this in vitro ischemic model. OGD also triggered the activation of calpains, proteases known to mediate many deleterious effects in post-ischemic neurons. We then used microarray technology to study changes in the transcriptome of rat hippocampal neurons submitted to OGD. For that purpose, total RNA was extracted 7h and 24h after OGD and used in a whole-genome RNA microarray to identify genes related to an early and a delayed ischemic response. At 7h of recovery there is a general repression of genes, while at 24h there is a general induction of gene expression. Analysis of the gene ontology showed that genes related with a variety of cellular functions, such as the response to oxidative stress, metabolism, apoptosis, synapse and ion channel activity, were differently regulated after OGD. As far as we know, no previous study has used microarray technology and the OGD model as a tool to investigate ischemia-induced changes in the transcriptome of hippocampal neurons at different periods of recovery. The validity of the microarray data was confirmed by qPCR analysis of selected genes from different functional groups. According to the microarray data, several synaptic protein genes were down-regulated after OGD. We also observed that OGD triggers the up-regulation of REST, a transcription factor that represses the expression of genes related with the synaptic function. Additionally, OGD decreased the mRNA and protein levels of the GluA1 AMPAR subunit as well as the GluN2A and GluN2B subunits of NMDARs, but increased the mRNA expression of the NMDAR subunit GluN3A, which might lead to a change in the composition of ionotropic glutamate receptors in hippocampal neurons. These results suggest that OGD activates a transcriptional program leading to a general repression of proteins present in the synapse. Moreover, we analyzed OGD-induced changes in the expression levels of ion channel protein genes. In particular, we pursued the contribution of the chloride channel CLIC1 to the OGD-mediated neuronal response. The role of CLIC1 in neurons is largely unknown but it has been suggested to contribute to neuronal death when activated in microglia under toxic conditions. However, we observed that neurons over-expressing CLIC1 are less vulnerable to OGD-induced cell death, and preliminary results suggest that CLIC1 may be up-regulated in the hippocampal regions that are more resistant to ischemia. Overall, these results suggest that CLIC1 can be part of an intrinsic protective mechanism activated in neurons after an ischemic insult. The results obtained in this work present the global expression profile elicited by in vitro ischemia in hippocampal neurons, and help to investigate two different mechanisms that may contribute to neuronal survival in neurons submitted to OGD: decrease in the expression of synaptic components, namely those involved in excitotoxicity, and up-regulation of the chloride channel CLIC1. The targets that we identified may be explored to develop attractive therapeutic strategies for the treatment of cerebral ischemia.
Videira, Raquel Figuinha. « Cardiac ischemia-reperfusion injury : in vitro models and regulation by microRNAs ». Master's thesis, 2016. http://hdl.handle.net/10316/99215.
Texte intégralCardiovascular diseases, including myocardial infarction, are a leading cause of morbidity and mortality worldwide. Ischemia is a major event during myocardial infarction and results from the deprivation of blood to the heart, caused by the obstruction of a coronary artery. Reperfusion, i.e. the restoration of blood flow following an ischemic event, is the routine clinical procedure. Although reperfusion is essential to preserve the hypoxic myocardium, the sudden reoxygenation of the hypoxic tissues has important adverse effects, including initiation of cell death programs. This phenomenon, known as ischemia-reperfusion injury, is responsible for a fraction of the myocyte death observed following myocardial infarction. Since the human heart has limited regenerative capacity, dead cardiomyocytes are not renewed and, instead, a reparative scarring mechanism occurs. Cardiac fibrosis promoted by cardiac fibroblasts is the principal event underlying scar formation. Upon ischemia-reperfusion injury, cardiac fibroblasts increase their proliferative rate and transform into a contractile and active form, called myofibroblasts. Myofibroblasts are hyper stimulated cells, that produce large amounts of ECM proteins such as collagens, contributing to ECM deposition. Although fibrosis is essential to mending a damaged heart, excessive scarring and persistence of myofibroblasts in the heart is a maladaptive event that leads to ventricle wall stiffness and impairment of heart function. To minimize the effects caused by myocardial infarction, two main therapeutic endpoints could be pursued: i) increase of cardiomyocyte proliferation, to promote replacement of cells lost upon injury, and ii) blocking of excessive scarring process and fibrosis, which contributes to heart dysfunction. MicroRNAs are endogenous small non-coding RNAs that play a major role in the posttranscriptional regulation of gene expression. Currently, 2,588 mature microRNAs are annotated in the human genome (miRBase Release 21, June 2014) and it is estimated that microRNAs might control the expression of ca. 60% of the human genes. MicroRNAs have been shown to be involved in diverse cellular functions such as proliferation, differentiation and apoptosis. The observation that each microRNA can regulate multiple target transcripts, together with the fact that microRNA expression can be modulated by synthetic molecules that mimic or prevent microRNA function (microRNA mimics and inhibitors, respectively), position microRNAs as attractive therapeutic tools. This project is focused on the two main pathological events of myocardial infarction, ischemia-reperfusion and fibrosis, and the potential role of microRNAs in regulating these processes. In the first stage of the project, we optimized experimental conditions to model cardiac ischemia-reperfusion injury in vitro and assessed the impact of injury to cardiomyocyte survival. For this purpose, we used two sources of human cardiomyocytes, both derived from induced pluripotent stem cells. Cells were first exposed to ischemia, achieved by incubation in a hypoxic environment for 24 or 48 hours in the absence of nutrients (except lactate in selected conditions) and subsequently returned to normal culturing conditions, mimicking the reperfusion step. We observed a strong decrease of cardiomyocyte number following ischemia-reperfusion injury, accompanied by changes in cell morphology. In addition, we also optimized a reverse transfection protocol that can be used for transfection of microRNAs in large-scale screenings aimed at clarifying the role of microRNAs in ischemia-reperfusion injury. From these experiments, we were able to demonstrate that hsa-miR-302d-3p strongly induces proliferation of human cardiomyocytes. The second stage of the project was focused on human cardiac fibroblasts. Cardiac fibroblasts were exposed to ischemia-reperfusion injury in vitro using a protocol similar to that applied for cardiomyocytes. Interestingly, our results suggested that ischemiareperfusion leads to a slight increase of cardiac fibroblast proliferation, which is triggered by reperfusion. A reverse transfection protocol for microRNA transfection was also optimized and we performed a “proof-of-principle” pilot screening with 36 microRNAs, aiming at identifying microRNAs controlling myofibroblast activation. Among those, we identified microRNAs that have a strong activity in promoting (hsa-miR-26b-5p, hsa-miR-19b-2-5p, hsamiR- 2052, hsa-miR-875-5p, hsa-miR-210-3p and hsa-miR-19a-5p) or preventing (hsa-miR- 1281, hsa-miR-130a-5p and hsa-miR-143-5p) myofibroblast activation. Additionally, it was also possible to establish a preliminary correlation between cardiac fibroblast activation and proliferation after microRNA treatment. Our findings indicate that cardiac fibroblasts transformation into myofibroblasts results in a significant decrease of their proliferation rate. Overall, this study has established the experimental conditions for performing largescale screening studies in human cardiomyocytes and cardiac fibroblasts, which will be important to identify novel microRNAs involved in ischemia-reperfusion injury.
As doenças cardiovasculares, nomeadamente o enfarte do miocárdio, são uma das principais causas de morbilidade e mortalidade a nível mundial. A isquémia é o principal acontecimento de um enfarte do miocárdio, e resulta da obstrução de uma artéria coronária, reduzindo o fluxo sanguíneo no coração. A reperfusão é uma intervenção médica na qual o fluxo sanguíneo é restabelecido após isquémia. Apesar de essencial à preservação do miocárdio isquémico, a rápida reoxigenação provocada pela reperfusão tem efeitos devastadores no tecido cardíaco, que incluem a ativação de mecanismos de morte celular. Este fenómeno, conhecido como lesão de isquémia-reperfusão, é em parte responsável pela morte de cardiomiócitos observada após o enfarte do miocárdio. Uma vez que o coração humano é incapaz de se regenerar, os cardiomiócitos danificados não são repostos e, em vez disso, é ativado um mecanismo reparador, conhecido como cicatrização. A fibrose cardíaca promovida por fibroblastos cardíacos é o principal evento subjacente à formação da cicatriz. Após exposição a isquémia-reperfusão, os fibroblastos cardíacos aumentam a sua taxa proliferativa e transformam-se numa forma ativa e contrátil denominada de miofibroblastos. Os miofibroblastos são células híper estimuladas, que produzem grandes quantidades de proteínas de matriz extracelular (MEC), nomeadamente colagénio, contribuindo assim para a deposição de MEC. Embora a fibrose seja essencial para reparar danos cardíacos, a excessiva cicatrização e a permanência de miofibroblastos no coração é um processo patológico que pode conduzir à rigidez da parede do ventrículo, deteriorando a função cardíaca. Para diminuir os efeitos provocados pelo enfarte do miocárdio, duas abordagens terapêuticas podem ser implementadas: i) aumentar a proliferação de cardiomiócitos para promover a substituição das células danificadas durante o enfarte e ii) bloquear a cicatrização excessiva e fibrose cardíaca, que contribuem para a disfunção cardíaca. MicroARNs são pequenos ARN endógenos não-codificantes, que desempenham um papel chave na regulação pós-transcricional da expressão de genes. Atualmente, estão descritos 2588 microARNs maduros no genoma humano (miRBase Release em 21, Junho 2014) e é estimado que estes microARNs possam controlar até 60% da expressão de genes humanos. Foi demonstrado que os microARNs estão envolvidos em diversas funções celulares como a proliferação, diferenciação celular e apoptose. A observação de que cada microARN é capaz de regular vários transcritos alvo, conjuntamente com o facto de que a sua expressão pode ser modulada por moléculas sintéticas que mimetizam ou antagonizam a função de cada microARN (mímicos ou inibidores de microARNs, respetivamente), posicionam os microARNs como atrativas ferramentas terapêuticas. Este projeto foca-se nos dois eventos patológicos associados ao enfarte do miocárdio, nomeadamente, a isquémia-reperfusão e a fibrose cardíaca, e no potencial papel dos microARNs na regulação destes processos. A primeira parte deste projeto visou a otimização das condições experimentais para mimetizar os danos provocados pela isquémia-reperfusão cardíaca, e posteriormente, a avaliação do impacto desses mesmos danos na sobrevivência dos cardiomiócitos. Para tal, foram usados cardiomiócitos humanos de duas origens diferentes, mas ambos derivados de células estaminais pluripotentes induzidas. As células foram expostas a isquémia, obtida através de incubação das células num ambiente hipóxico, durante 24 ou 48 horas na ausência de nutrientes (exceto lactato, em condições específicas), e subsequentemente, devolvidas às condições normais de cultura, simulando o passo da reperfusão. Após a lesão de isquémiareperfusão observou-se um forte decréscimo no número de cardiomiócitos, acompanhado por alterações na morfologia celular. Adicionalmente, foi também possível otimizar o protocolo de transfeção reversa de microARNs que poderá ser usado para a realização de um screening de larga escala com o objetivo de clarificar o papel dos microARNs na lesão de isquémia-reperfusão. Através destas experiências foi possível demonstrar que o hsa-miR- 302d-3p induz um forte aumento da capacidade proliferativa de cardiomiócitos humanos. A segunda fase do projeto focou-se em fibroblastos cardíacos humanos. Os fibroblastos cardíacos foram expostos a lesão de isquémia-reperfusão in vitro usando um protocolo semelhante ao utilizado em cardiomiócitos. Curiosamente, os resultados obtidos sugerem que a isquémia-reperfusão leva a um ligeiro aumento da proliferação de fibroblastos cardíacos, que é estimulado pela reperfusão. O protocolo de transfeção reversa para microARNs foi também otimizado, e foi realizado ainda um screen piloto com 36 microRNAs, que serviu de “prova de princípio” para a validação da tecnologia e identificação de microARNs que controlam a ativação de miofibroblastos. De entre os microRNAs testados, identificámos microARNs com um efeito marcante na estimulação (hsa-miR-26b-5p, hsa-miR- 19b-2-5p, hsa-miR-2052, hsa-miR-875-5p, hsa-miR-210-3p e hsa-miR-19a-5p) ou na repressão (hsa-miR-1281, hsa-miR-130a-5p e hsa-miR-143-5p) da ativação de miofibroblastos. Adicionalmente, foi também possível estabelecer uma correlação preliminar entre a ativação e a proliferação dos fibroblastos cardíacos após tratamento com microARNs. Os nossos resultados indicam que a transformação de fibroblastos cardíacos em miofibroblastos resulta num significativo decréscimo da sua taxa de proliferação. Em geral, este estudo estabeleceu as condições experimentais necessárias à realização de um screen em larga escala em cardiomiócitos e fibroblastos cardíacos humanos, que será importante para a identificação de novos microARNs envolvidos na lesão de isquémia-reperfusão.
Vieira, Marta. « Molecular Mechanisms Underlying in vitro Cerebral Ischemia : Multiple Neuronal Death Pathways ». Doctoral thesis, 2014. http://hdl.handle.net/10316/24088.
Texte intégralCerebral global ischemia induces selective neurodegeneration of specific subsets of neurons throughout the brain, namely in the CA1 region of the hippocampus. Despite its high prevalence and intensive research, there is still need of effective treatments to reduce the neurodegeneration associated with global ischemia. This pathology can be studied in vitro by depriving neurons of oxygen and glucose (OGD). Our main goal was to study the molecular mechanisms of neuronal death activated by OGD in primary cultures of hippocampal neurons. For this purpose we targeted distinct aspects of cell death. We studied the excitotoxic component of cell death mediated by NMDARs, we addressed the activation of a novel mechanism of programmed cell death, necroptosis, and we analyzed the activation of effector signaling cascades, in particular MAPKs. We started by studying the influence of the GluN2B subunit of NMDARs to OGD-induced neuronal demise. NMDARs are major contributors to the overload of intracellular Ca2+ characteristic of excitotoxicity and the role of GluN2 subunits has remained controversial. This is due to a variety of conflicting evidence showing that either both GluN2A and GluN2B contribute to neuronal death or that GluN2B is mostly pro-death and GluN2A pro-survival. To clarify this question we used cultured cortical neurons from GluN2B-/- mice and wild-type littermates, and observed that GluN2B is determinant for induction of excitotoxic neuronal death following OGD. We observed that the absence of this subunit blocked neuronal death induced by OGD and that the toxicity was rescued when we reintroduced the subunit in the KO neurons. Moreover, we demonstrated that the C-terminal domain (CTD) had a preponderant role in GluN2B-induced toxicity, and we identified molecular determinants in the CTD of GluN2B responsible for this function. We confirmed that the PDZ-binding domain was partly responsible for NMDAR toxicity. This domain is responsible for the interaction with PSD95 that couples to nNOS, and interfering with this interaction was neuroprotective. Additionally, we identified two other regions on the GluN2B CTD that are required for OGD-induced cell death, the AP2- and the CaMKII-binding domains. Mutations in either of these sites blocked GluN2B-mediated toxicity. These findings confirmed the crucial role of GluN2B-containing NMDARs in a context of in vitro ischemia, and our study is particularly relevant since most previous work was performed under excitotoxic conditions. Next, we investigated whether OGD induced necroptosis, a novel type of programmed necrosis, in hippocampal neurons. This type of cell death has been recently described to occur following death receptor (DR) signaling. In certain conditions a complex called DISC is formed. DISC induces apoptosis and downregulates necroptosis via caspase8-mediated cleavage of the proteins RIP1/RIP3. However, when caspase8 is inhibited, RIP3 is recruited to RIP1 and together they form a complex called the necrosome, and activate necroptosis. We observed that OGD induced a component of cell death that was reversed by the necroptotic inhibitor Nec-1 but not by zVAD.fmk, an apoptotic inhibitor. Notably, we observed that Nec-1 had no effect on the apoptotic component of neuronal death. Additionally, OGD induced the expression of RIP1 and RIP3. We confirmed the toxic role of RIP3 by performing overexpression and knock-down experiments. We observed that overexpression of both RIP1 and RIP3 exacerbated neuronal death induced by OGD whereas knockdown of RIP3 significantly reduced OGD-mediated toxicity. The damaging effect of the OGD challenge was rescued by reintroducing RIP3 in neurons where endogenous RIP3 was knocked-down, confirming the specificity of the requirement for RIP3. Finally, we correlated these in vitro events with the in vivo challenge, by confirming that global cerebral ischemia in the rat also induces RIP3 expression in the CA1 area of the hippocampus. Lastly, we studied the activation of MAPKs in hippocampal neurons submitted to OGD. These kinases are responsible for the majority of the cellular response to stress and are involved in several paradigms of cell death, including in neurons. We determined that both p38 and JNK are activated following OGD, at 2h and 6h of reoxygenation, respectively. Furthermore, inhibition of the activity of these MAPKs has a neuroprotective effect, suggesting a cytotoxic function. Interestingly, JNK seems to have biphasic function since neuroprotection was only achieved when we inhibited JNK at 4h reoxygenation. Overall, our results demonstrate that OGD induces a variety of changes in neurons, including several mechanisms that contribute to neurodegeneration. This in vitro model is thus a powerful tool to address the molecular mechanisms underlying cerebral ischemia, which may provide useful insights into the development of therapeutic strategies to this pathology.
A isquemia cerebral induz neurodegeneração de populações específicas de neurónios, nomeadamente na área CA1 do hipocampo. Apesar da sua elevada prevalência e dos esforços na investigação, não existem actualmente tratamentos eficazes para prevenir a neurodegeneração associada à isquemia global. Esta patologia pode ser estudada in vitro submetendo os neurónios a privação de oxigénio e glicose (OGD, do inglês “oxygen and glucose deprivation”). O principal objectivo deste trabalho foi o de estudar os mecanismos moleculares associados à morte neuronal iniciada pela OGD em culturas primárias de neurónios de hipocampo. Para este propósito pesquisámos diferentes aspectos da morte celular. Assim, estudámos o fenómeno de excitotoxicidade mediada por receptores de glutamato do tipo NMDA (NMDARs), analisámos a activação de um novo mecanismo de morte celular, necroptose, e verificámos a activação de vias efectoras da morte celular, em particular, as vias das MAPKs. Começámos por estudar a influência da subunidade GluN2B dos NMDARs na morte neuronal induzida por OGD. Os NMDARs têm um papel de relevo no excesso de Ca2+ intracelular característico da excitotoxicidade; contudo, o papel das subunidades GluN2 tem permanecido controverso. Há evidências que mostram o envolvimento das subunidades GluN2A e GluN2B no processo de morte celular enquanto outras mostram o papel tóxico do GluN2B e uma função neuroprotectora do GluN2A. Para clarificar esta questão recorremos a um sistema de cultura neuronal de murganhos GluN2B-/- e observámos um papel determinante da subunidade GluN2B na indução de morte após OGD em neurónios de córtex. Verificámos que a ausência do GluN2B eliminou a toxicidade induzida por OGD, que foi recuperada com a reintrodução da subunidade nos neurónios GluN2B-/-. Demonstrámos ainda o papel preponderante do domínio C-terminal (CTD) da subunidade na toxicidade mediada por GluN2B e mapeámos alguns locais de interacção no CTD de GluN2B responsáveis por esta função tóxica. O domínio PDZ é responsável pela interacção com a PSD95, que faz o acoplamento à nNOS. A interferência com esta interacção teve um efeito neuroprotector. Identificámos também dois determinantes moleculares no CTD de GluN2B relevantes para este processo, o local de ligação às proteínas AP2 e CaMKII. A mutação destes locais eliminou a toxicidade induzida pela subunidade GluN2B. Estas evidências apoiam o papel determinante dos NMDARs contendo GluN2B num contexto de isquemia cerebral in vitro. O nosso estudo é particularmente relevante na medida em que os trabalhos anteriores utilizavam, na sua maioria, estímulos excitotóxicos. De seguida, investigámos a indução de morte neuronal por necroptose, um novo mecanismo de necrose programada, em neurónios de hipocampo submetidos a OGD. Este tipo de morte celular ocorre na sequência da activação de “death receptors” (DRs). Em determinadas condições, ocorre a formação de um complexo que medeia a apoptose e inibe a necroptose através da clivagem das proteínas RIP1/3. Contudo, se ocorrer inibição da caspase8, a RIP3 é recrutada para a RIP1 e juntas formam um complexo chamado necrosoma, que activa a necroptose. A OGD induziu um componente de morte celular que foi revertido pelo inibidor de necroptose Nec-1, mas não pelo inibidor da apoptose zVAD.fmk. A especificidade do efeito protector da Nec-1 sobre a necroptose foi comprovada pela ausência de efeito da Nec- 1 no componente apoptótico. Além disso, a OGD induziu a expressão das proteínas RIP1 e RIP3. Confirmámos o papel tóxico da RIP3 através de ensaios de sobreexpressão e silenciamento. A sobreexpressão das proteínas RIP1 e RIP3 aumentou a morte neuronal, enquanto o silenciamento da RIP3 reduziu a toxicidade induzida por OGD. O efeito tóxico da OGD foi recuperado com a reintrodução da proteína RIP3 em neurónios sem RIP3 endógena. Por fim, relacionámos os mecanismos observados in vitro com o modelo in vivo, ao observarmos que a isquemia global induz o aumento da expressão da RIP3 na área CA1 do hipocampo. Estudámos por fim a activação de MAPKs em neurónios de hipocampo submetidos a OGD. Estas cinases são responsáveis pela resposta ao stress celular e estão envolvidas em diversos paradigmas de morte neuronal. Verificámos a activação das cinases p38 e JNK após OGD, às 2h e 6h de recuperação, respectivamente. Verificámos ainda que a inibição destas cinases teve um efeito protector, o que sugere um papel citotóxico. Curiosamente, a cinase JNK parece ter um duplo papel, já que a sua inibição só foi protectora quando efectuada às 4h após o estímulo de OGD. Concluindo, os nossos resultados demonstram que a OGD afecta os neurónios a vários níveis, incluindo na indução de mecanismos que contribuem para a neurodegeneração. Este modelo in vitro apresenta-se assim como uma ferramenta importante para a dissecção de mecanismos moleculares subjacentes à isquemia cerebral, o que poderá contribuir para o desenvolvimento de estratégias terapêuticas para esta patologia.
« Actions of protease activated receptors in in vivo and in vitro models of stroke ». 2014. http://repository.lib.cuhk.edu.hk/en/item/cuhk-1291499.
Texte intégralIn the present study, the roles of PARs were examined in two models of ischaemic stroke. For the in vivo model, transient middle cerebral artery occlusion (tMCAO) was performed to establish cerebral ischaemia in rats. For the in vitro model, oxygen and glucose deprivation (OGD) was used to mimic an ischaemia insult in primary cultured rat embryonic cortical neurones.
Western blot studies showed that expressions of PAR-1 and PAR-2 were increased in the rat ischaemic brain cortex, whereas PAR-1 was reduced in the rat cortical neurones subjected to OGD. Pretreatments of PAR-1 AP (SFLLRN-NH₂) and PAR-2 AP (SLIGRL-NH₂) produced significant protection against ischaemia-induced damage. Pretreatment of PAR-3 AP (SFNGGP-NH₂) only improved ischaemic symptoms in in vivo but not in in vitro model. When treated after ischaemia, only PAR-1 AP produced significant reductions on ischaemia-induced damage. Protective actions of PAR-1 and PAR-2 APs were inhibited by PAR-1 antagonist (BMS-200261) and PAR-2 antagonist (ENMD-1068) respectively, but PAR-1 antagonist did not affect posttreatment effects of PAR-1 AP in in vitro model. Pre- and posttreatments of thrombin, and pretreatment of trypsin also protected ischaemia-induced damage in the two models.
PAR-1 AP produced marked increase in the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), and ratio of bcl-2/bax, but reduced contents of reactive oxygen species (ROS), nitric oxide (NO) and malondialdehyde (MDA) in both ipsilateral ischaemic brain cortices and in rat cortical neurones subjected to OGD. In the in vitro model, PAR-1 AP greatly decreased caspase-3 activity and TUNEL positive cells, while markedly increased mitochondrial membrane potential (MMP). All these protective actions were inhibited by its antagonist, which suggests it was mediated via activation of PAR-1.
In MCA isolated from normal and ischameic rats, PAR-2 AP and trypsin produced vasodilatation while PAR-3 AP elicited vasoconstriction. However, another PAR-3 AP had no effect in the two types of MCA. A high concentration of PAR-1 AP relaxed MCA isolated form ischaemic rats, and it was not inhibited by a PAR-1 antagonist. The vasodilator action of PAR-2 AP was inhibited by one of two PAR-2 antagonists tested. The vasodilator actions induced by PAR-1 and PAR-2 APs involved NO production since L-NAME was effective in inhibiting their actions.
In conclusion, PAR-1 AP was found to be the most efficacious in protecting the brain from ischaemia-induced damage when administered either before or after ischaemia insults. The protective actions were likely to be attributed to its anti-oxidant properties in the ischaemic brain that reduced apoptosis of brain cells. Therefore, PAR-1 was identified as a promising target for development of novel prophylactic and therapeutic treatments of ischaemic brain disease.
缺血性腦中風已經成為全世界導致死亡和殘疾的最主要的疾病之一。蛋白酶激活受體(PARs, PAR-1 to PAR-4)屬於G蛋白偶聯受體並且可以通過蛋白水解生成系鎖配體(TL)從而作用於受體本身而激活信號通路。根據TL的序列已經合成了很多激活肽和拮抗劑,它們可以作為有價值的工具藥進行PAR的作用研究。
當前,PAR的作用在兩個缺血性腦中風模型中進行研究。體內模型是通過大鼠大腦中動脈阻塞手術而建立;體外模型是通過對大鼠胚胎大腦皮層神經元進行氧糖剝奪模擬缺血性損傷。
蛋白質印跡法的實驗表明PAR-1和PAR-2的表達在缺血側大腦皮層中有所增多,而PAR-1在氧糖剝奪的大鼠皮層神經元中表達卻有所降低。預處理PAR-1(SFLLRN-NH₂)和PAR-2(SLIGRL-NH₂)的激活肽顯著改善了缺血導致的損傷。預處理PAR-3激活肽(SFNGGP-NH₂)僅僅改善了體內缺血症狀,卻對體外缺血模型沒有效果。然而,當這些激活肽在缺血后給予的時候,只有PAR-1的激活肽顯著改善了缺血損傷。PAR-1的拮抗劑(BMS-200261)和PAR-2的拮抗劑(ENMD-1068)抑制了PAR-1和PAR-2激活肽的保護作用,但是體外實驗後處理PAR-1激活肽的保護作用卻未收影響。預處理及後處理凝血酶,預處理胰酶都在這兩個模型中顯示出保護缺血性損傷的作用。
PAR-1激活肽在缺血同側大腦皮層以及經受氧糖剝奪的大鼠皮層神經元中,顯著提高了超氧化物歧化酶(SOD)、過氧化氫酶(CAT)、谷胱甘肽過氧化物酶(GSH-Px)的活力以及bcl-2/bax的比例,同時顯著降低了活性氧自由基(ROS)、一氧化氮(NO)以及丙二醛(MDA)的含量。在體外模型中,PAR-1激活肽還顯著降低了caspase-3的活力以及TUNEL陽性細胞的比例,同時顯著提高了線粒體膜電位(MMP)。所有這些作用都可以被拮抗劑抑制,說明PAR-1激活肽的保護作用是通過激活PAR-1介導的。
不管是從正常還是缺血的大鼠中分離出來的大腦中動脈,PAR-2激活肽和胰酶都可以使之舒張,PAR-3激活肽卻對其有收縮作用。然而,另外一種PAR-3激活肽卻未顯現出對血管活性的影響。高劑量的PAR-1激活肽只可以在分離于缺血大鼠的大腦中動脈中引起舒張,但此作用不能被其拮抗劑所抑制。PAR-2激活肽導致的血管舒張只可以被檢測的兩個拮抗劑中的其中一個所抑制。PAR-1和PAR-2激活肽引起的血管舒張與NO的產生有關,因為L-NAME可以有效抑制它們的作用。
總之,不管是預處理還是後處理的給藥方式,PAR-1的激活肽在保護大腦的缺血性損傷中都是最有效果的。保護作用可能可以歸因于其抗氧化以及抗凋亡的特性。所以,PAR-1是研究防治缺血性腦疾病的發展中富有希望的一個靶點。
Zhen, Xia.
Thesis Ph.D. Chinese University of Hong Kong 2014.
Includes bibliographical references (leaves 194-206).
Abstracts also in Chinese.
Title from PDF title page (viewed on 11, October, 2016).
Detailed summary in vernacular field only.
Detailed summary in vernacular field only.
Detailed summary in vernacular field only.
Detailed summary in vernacular field only.
Detailed summary in vernacular field only.
Detailed summary in vernacular field only.
« In vitro and in vivo effects of thrombopoietin on protection against hypoxia-ischemia-induced neural damage ». 2008. http://library.cuhk.edu.hk/record=b5893561.
Texte intégralThesis (M.Phil.)--Chinese University of Hong Kong, 2008.
Includes bibliographical references (leaves 107-128).
Abstracts in English and Chinese.
Abstract --- p.i
中文摘要 --- p.iv
Acknowledgements --- p.vi
Publications --- p.viii
Table of Contents --- p.ix
List of Tables --- p.xiv
List of Figures --- p.xv
List of Abbreviations --- p.xviii
Chapter Chapter 1 --- Introduction --- p.1
Chapter 1.1 --- Hypoxic-ischemic encephalopathy in human infants --- p.1
Chapter 1.1.1 --- Incidence --- p.1
Chapter 1.1.2 --- Biphasic development of HI brain damage --- p.2
Chapter 1.1.2.1 --- Initiating mechanism: energy failure in immature brain --- p.3
Chapter 1.1.2.2 --- Biochemical cascades --- p.4
Chapter 1.1.2.2.1 --- Excitatory amino acid receptor activation by glutamate --- p.4
Chapter 1.1.2.2.2 --- Intracellular calcium accumulation --- p.4
Chapter 1.1.2.2.3 --- Formation of free radicals --- p.5
Chapter 1.1.2.2.3.1 --- Reactive oxygen species (ROS) --- p.5
Chapter 1.1.2.2.3.2 --- Nitric oxide (NO) --- p.6
Chapter 1.1.2.3 --- Release of inflammatory mediators --- p.6
Chapter 1.1.2.4 --- Mitochondrial dysfunction --- p.7
Chapter 1.1.2.5 --- Final path to death: necrosis or apoptosis --- p.8
Chapter 1.1.2.6 --- Ways to change: neuronal survival and proliferation signaling --- p.8
Chapter 1.1.3 --- Interventions for neonatal hypoxia-ischemia --- p.9
Chapter 1.2 --- Animal models mimicking hypoxia-ischemia brain injury --- p.12
Chapter 1.2.1 --- Comparisons of animal models of hypoxia-ischemia --- p.12
Chapter 1.2.2 --- Development of neonatal rat model with hypoxic-ischemic damage --- p.14
Chapter 1.3 --- Neural stem/progenitor cells --- p.15
Chapter 1.3.1 --- Effect of hypoxic-ischemia on neural stem/progenitor cells --- p.17
Chapter 1.4 --- Thrombopoietin --- p.18
Chapter Chapter 2 --- Objectives --- p.23
Chapter Chapter 3 --- Materials and Methodology --- p.24
Chapter 3.1 --- Establishment of neonatal rat model of HI brain damage and effects of TPO on neural protection --- p.24
Chapter 3.1.1 --- Animal protocols --- p.24
Chapter 3.1.2 --- Induction of HI brain damage in neonatal rats --- p.24
Chapter 3.1.3 --- Treatment with TPO --- p.25
Chapter 3.1.4 --- Sacrifice of rats --- p.25
Chapter 3.1.5 --- Read-out measurements --- p.26
Chapter 3.1.5.1 --- Brain weight --- p.26
Chapter 3.1.5.2 --- Gross injury assessment of the right hemisphere --- p.26
Chapter 3.1.5.3 --- Histology --- p.27
Chapter 3.1.5.4 --- Blood cell count --- p.27
Chapter 3.1.5.6 --- Functional assessments --- p.28
Chapter 3.1.5.6.1 --- Grip traction test --- p.28
Chapter 3.1.5.6.2 --- Elevated body swing test --- p.28
Chapter 3.1.5.7 --- Statistical analysis --- p.28
Chapter 3.2 --- Establishment of in vitro model of primary mouse NSPs and the effect of TPO on their proliferation --- p.29
Chapter 3.2.1 --- Mouse embryo dissection for the extraction of NSP --- p.29
Chapter 3.2.2 --- Culturing of NSP --- p.30
Chapter 3.2.3 --- Immunofluorescence staining for stem cell markers --- p.31
Chapter 3.2.4 --- Neurosphere assay with different combinations of mitogens --- p.31
Chapter 3.2.5 --- Neurosphere assay with different concentrations of TPO --- p.32
Chapter 3.2.6 --- Neurosphere assay under hypoxia --- p.32
Chapter 3.2.7 --- Statistical analysis --- p.33
Chapter Chapter 4 --- Effects of thrombopoietin on neonatal rat models of hypoxia-ischemia brain damage --- p.39
Chapter 4.1 --- Summary of experimental settings --- p.39
Chapter 4.2 --- Results --- p.39
Chapter 4.2.1 --- Mortality --- p.39
Chapter 4.2.2 --- Effects of TPO on p7 mild damage model 1 week post-surgery --- p.40
Chapter 4.2.2.1 --- Body and brain weights --- p.40
Chapter 4.2.2.2 --- Gross injury score --- p.41
Chapter 4.2.2.3 --- Cortex and hippocampus area --- p.41
Chapter 4.2.2.4 --- Blood cell counts --- p.42
Chapter 4.2.3 --- Effects of TPO on p7 severe damage model 1 week post-surgery --- p.43
Chapter 4.2.3.1 --- Body and brain weights --- p.43
Chapter 4.2.3.2 --- Gross injury score --- p.43
Chapter 4.2.3.3 --- Cortex area --- p.44
Chapter 4.2.3.4 --- Blood cell counts --- p.44
Chapter 4.2.4 --- Effects of TPO on p7 severe damage model 3 week post-surgery --- p.45
Chapter 4.2.4.1 --- Body and brain weights --- p.45
Chapter 4.2.4.2 --- Gross injury score --- p.46
Chapter 4.2.4.3 --- Blood cell counts --- p.46
Chapter 4.2.4.4 --- Functional outcomes --- p.46
Chapter 4.2.5 --- Effects of TPO on pl4 severe damage model 1 week post-surgery --- p.47
Chapter 4.2.5.1 --- Body and brain weights --- p.47
Chapter 4.2.5.2 --- Gross injury score --- p.48
Chapter 4.2.5.3 --- Cortex area --- p.48
Chapter 4.2.5.4 --- Blood cell counts --- p.49
Chapter 4.3 --- Discussion --- p.49
Chapter Chapter 5 --- Effects of thrombopoietin on the proliferation of primary mouse neural stem/ progenitor cells in culture --- p.83
Chapter 5.1 --- Summary of experimental settings --- p.83
Chapter 5.2 --- Results --- p.83
Chapter 5.2.1 --- Effect of EGF or bFGF withdrawal on NSP proliferation --- p.84
Chapter 5.2.2 --- Dose effect of TPO treatment on NSP proliferation --- p.85
Chapter 5.2.3 --- Effect of hypoxia --- p.85
Chapter 5.2.4 --- Effect of TPO treatment in combination with hypoxia --- p.86
Chapter 5.2.5 --- Detection of neural progenitor cell marker --- p.87
Chapter 5.3 --- Discussion --- p.88
Chapter Chapter 6 --- General discussion --- p.101
Bibliography --- p.106